About Synapse
Overview
Disclaimer
Journal list
Advanced
Contact us
Search Guidelines
How to Participate
How to add a journal to Synapse
How to submit a file after validating the JATS XML file
File Validation tools
KAMJE Databases
KoreaMed
KoMCI
Korean Medical Journal Information
KAMJE
About Synapse
Overview
Disclaimer
Journal list
Advanced
Contact us
Search Guidelines
How to Participate
How to add a journal to Synapse
How to submit a file after validating the JATS XML file
File Validation tools
KAMJE Databases
KoreaMed
KoMCI
Korean Medical Journal Information
KAMJE
-Advanced
-Search Guidelines
Home
Journal List
Cardiovasc Prev Pharmacother
Go to Top
Go to Top
Go to Bottom
Go to Bottom
Cardiovasc Prev Pharmacother >
v.8(3)
6 results
47
Declining diabetes mortality and widening regional disparities in Korea (1998–2024)
Declining diabetes mortality and widening regional disparities in Korea (1998–2024)
Minsung Cho, Kyoung Hwa Ha, Hokyou Lee, Hyeon Chang Kim
Minsung Cho, Kyoung Hwa Ha, Hokyou Lee, Hyeon Chang Kim
KMSID: 1516096735
Cardiovasc Prev Pharmacother.
2026;8(3):47-55. Published online 2026 July 30 DOI:
http://dx.doi.org/10.36011/cpp.2026.8.e11
56
Beyond declining mortality: toward equitable cardiometabolic prevention
Beyond declining mortality: toward equitable cardiometabolic prevention
Moon-Seung Soh
Moon-Seung Soh
KMSID: 1516096734
Cardiovasc Prev Pharmacother.
2026;8(3):56-57. Published online 2026 July 28 DOI:
http://dx.doi.org/10.36011/cpp.2026.8.e6
58
Association of leptin and ghrelin changes with weight response after dapagliflozin treatment in type 2 diabetes: a prospective interventional study
Association of leptin and ghrelin changes with weight response after dapagliflozin treatment in type 2 diabetes: a prospective interventional study
Jun Hwa Hong
Jun Hwa Hong
KMSID: 1516096730
Cardiovasc Prev Pharmacother.
2026;8(3):58-66. Published online 2026 July 28 DOI:
http://dx.doi.org/10.36011/cpp.2026.8.e9
67
Leptin, ghrelin, and the weight paradox of sodium-glucose cotransporter 2 (SGLT2) inhibition: a new piece of an old puzzle
Leptin, ghrelin, and the weight paradox of sodium-glucose cotransporter 2 (SGLT2) inhibition: a new piece of an old puzzle
Jin Oh Na
Jin Oh Na
KMSID: 1516096732
Cardiovasc Prev Pharmacother.
2026;8(3):67-68. Published online 2026 July 23 DOI:
http://dx.doi.org/10.36011/cpp.2026.8.e7
69
Body weight variability and the risk of incident metabolic dysfunction–associated steatotic liver disease (MASLD): a retrospective cohort study from the Kangbuk Samsung Health Study
Body weight variability and the risk of incident metabolic dysfunction–associated steatotic liver disease (MASLD): a retrospective cohort study from the Kangbuk Samsung Health Study
Eun-Jung Rhee, Won-Young Lee
Eun-Jung Rhee, Won-Young Lee
KMSID: 1516096731
Cardiovasc Prev Pharmacother.
2026;8(3):69-77. Published online 2026 July 28 DOI:
http://dx.doi.org/10.36011/cpp.2026.8.e10
78
Durability, not just magnitude: weight stability and the risk of metabolic dysfunction–associated steatotic liver disease (MASLD)
Durability, not just magnitude: weight stability and the risk of metabolic dysfunction–associated steatotic liver disease (MASLD)
Seo-Yeon Gwak
Seo-Yeon Gwak
KMSID: 1516096733
Cardiovasc Prev Pharmacother.
2026;8(3):78-80. Published online 2026 July 27 DOI:
http://dx.doi.org/10.36011/cpp.2026.8.e8
Articles from Cardiovascular Prevention and Pharmacotherapy are provided here courtesy of Korean Society of Cardiovascular Disease Prevention; Korean Society of Cardiovascular Pharmacotherap